viernes, 25 de noviembre de 2011

[OFER-TRABEC] NAC: Postdoctoral position Neurochemistry&Neurodegenera

------------------------
¿Necesitas distribución masiva y periodica de información?

RedIRIS te ofrece de forma gratuita su servicio Listas de distribución
http://www.rediris.es/list/crealist.html
*************************
(c)OFER-TRABEC es un servicio ofrecido por el Centro de Comunicaciones RedIRIS
(Permitida la reproducción siempre que se cite la fuente de este Servicio).
------------------------

---Procedencia:
Institución:Univ País Vasco/EHU/Univ Basque Country
Contacto correo-e:rafael.rodriguez@ehu.es
---
POSTDOCTORAL POSITION IN NEUROCHEMISTRY AND NEURODEGENERATION

University of the Basque Country. Bilbao. Spain.
Dept. Pharmacology. Faculty of Medicine.


Research lines:

- Neurochemistry of neurodegenerative diseases; Alzheimer.
(GPCR, autorradiography, immunohistochemistry, organotypic cultures, western blotting, learning test for rodents...).

- R+D in new analytical techniques applied to Neuropharmacology and drug discovery.
(Cell membranes microarrays, Imaging by mass spectrometry –IMS-, MALDI-TOF...).

Contract:

- Up to four years in a research project in collaboration with IMG Pharma Biotech LC. www.imgpharma.com.
- Salary up to 35K€/year, gross (before Taxes) depending on CV.

Requirements:

- Competitive CV, experience and record of publications in neuroscience/pharmacology (neurochemistry).
- Preferably ≥5 years postdoctoral experience (≥2 years not in Spain).
- Enthusiastic to work in the research lines of the group and supervise PhD students.
- Similar experience and requirements that apply for a "Ramon y Cajal" Contract (Spanish Ministry for Science).

----------------
Información complementaria de la oferta:
Contact to:

P.I. Rafael Rodríguez Puertas,. PhD
rafael.rodriguez@ehu.es

*************************************************************************
Para darse de baja OFER-TRABEC pinche y envíe:
mailto:OFER-TRABEC-signoff-request@listserv.rediris.es
*************************************************************************

No hay comentarios:

Publicar un comentario